Brought to you by 
Mitsubishi-Tokyo, NeoGenesis identify drug leads
02 Oct 2001
Executive Summary
NeoGenesis (applied genomics and chemistry) will use its drug discovery technologies to produce small-molecule drug leads to Mitsubishi-Tokyo Pharmaceuticals' targets.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Mitsubishi-Tokyo, NeoGenesis identify drug leads
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice